Navigation Links
Study Spotlights 'Exercise-Friendly' Day-Care Centers
Date:12/26/2007

Outdoor spaces and lots of portable toys get kids moving, researchers say

WEDNESDAY, Dec. 26 (HealthDay News) -- Access to the outdoors and portable toys can boost just how much exercise youngsters get at a day-care center, researchers say.

"Childhood obesity is an epidemic that threatens the future health of our nation. We know that about 57 percent of all 3- to 5-year-olds in the United States attend child-care centers, so it's important to understand what factors will encourage them to be more active, and, hopefully, less likely to become obese," study co-author Dianne Ward said in a statement. Ward is director of the intervention and policy division in the nutrition department at University of North Caroline at Chapel Hill School of Public Health.

In their study, Ward's team evaluated the physical activity levels of children at 20 child-care centers in North Carolina.

They found that children did more moderate and vigorous physical activity if the child-care center: had more portable play equipment, such as balls, jump ropes, hula hoops and riding toys; offered more opportunities for indoor and outdoor active play; and provided physical activity training and education for staff and students.

Climbing structures, swings, balance beams and other stationary playground equipment were associated with less intense physical activity. However, these items are beneficial to other aspects of child development, such as motor and social skills, the researchers noted.

Interestingly, children at day-care centers with more computer and television equipment had good physical activity scores, the study found.

"It's unlikely that TV and computers promoted active behavior, but it could be that centers that have the resources to buy media equipment may also spend more on equipment and activities that promote physical activity and provide supplemental training and education for staff," Ward said.

The
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Treatment site www.sleeping-with-a-sleeping-disorder.com is asking people ... natural sleep aids from around the world to ... cause. The submissions will be compiled in an ... YOU, to be sold from the website in ... of the proceeds ,from sales of the E-book ...
(Date:12/6/2009)... Joseph W. Belluck of Belluck & Fox, LLP says dangerous substances ... seasons. , ... New York, NY (PRWEB) December 6, ... season, they should be alert to reports of recalls due to ... lawyer., , ,“Close to 230,000 children visit hospital emergency rooms each ...
(Date:12/5/2009)... There have been significant scientific advances in the field ... a better understanding of how certain diseases progress in ... with the best care. Research presented today at the ... explores optimal induction therapies for managing multiple myeloma, the ...
(Date:12/5/2009)... TOWN, South Africa, December 5 The first ... of Cape Town opened its doors,today (5 December ... by,Western Cape Premier Helen Zille, 2010 FIFA World ... South African Football Association,President Kirsten Nematandani and Executive ...
(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and ... the 51st Annual Meeting of the American Society ... improved diagnostic methods for patients suffering from acute ... leukemia, and myelofibrosis that are based on a ...
Breaking Medicine News(10 mins):Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
... cancer. New research studies point towards its being preventable ... D and other vitamin D analogs, may help prevent ... at the American Association for Cancer Research's 4th annual ... ,The study funded by the National Institute of ...
... a donor sperm traces his genetic father using the DNA ... concerns about assisted reproduction that were not thought of when ... an unknown father using a donor sperm has succeeded in ... records and some ingenious Internet searches. ,The boy tracked ...
... new study says that a key enzyme present in skin ... the spread of the cancer to other parts of the ... is actually a critical component of the healthy cell and ... enzyme's less than helpful role in malignant melanoma or skin ...
... A dedicated 'organ transplant hospital' in the country ... a pioneering effort . ,Spread over a ... up by Hyderabad-based Global Hospitals Group,// headed by surgical gastro-enterologist ... hospital will have 750 beds and 150 full-time specialists in ...
... Zhengmin Chen and his team from Oxford University have ... heart attack patients may have more good effect in ... help in thinning of blood during a heart attack ... any serious side effects of bleeding. ,Researchers ...
... Downstate Medical Center in New York have discovered a ... the severity of atherosclerosis or blocked arteries.// ... teeth in 115 patients referred for transesophageal echocardiography (TEE) ... using this method. They also looked for the presence ...
Other Medicine News:Health News:Anonymous Sperm Donor Traced On Internet 2Health News:Global Hospitals coming to city of Joy 2
(Date:12/4/2009)... (NYSE Amex: PIP ), a biodefense company developing ... the presentation of new data from the Company,s anthrax ... (rPA) based anthrax vaccine is structurally stable and potent ... including 55 degrees C. The data were presented ...
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, today ... and Chief Financial Officer. In this role, Mr. ... functions including finance, accounting, IT, IR, administration and human ... senior management team. ,, "One of my key ...
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawford presented ... analysis of secondary end points of biochemical recurrence rate ... degarelix for injection) or monthly leuprolide in prostate cancer ... cancer patients who received FIRMAGON 240/80 mg/month had a ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4November Is Report Card Month 3A Tutorgiant com Suggests That Online Tutoring May Be The Solution To Bad Report Cards 61487 1November Is Report Card Month 3A Tutorgiant com Suggests That Online Tutoring May Be The Solution To Bad Report Cards 61487 2November Is Report Card Month 3A Tutorgiant com Suggests That Online Tutoring May Be The Solution To Bad Report Cards 61487 3New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 1New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 3New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 4Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 1Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 2Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 3
... Patent,Foundation ("PUBPAT") announced today that the U.S. Patent & ... by Gilead Sciences,that relate to the drug known generically ... battle against HIV/AIDS. Gilead markets TDF in,the United States ... of its ATRIPLA,combination product., Roughly 40 million people ...
... Genome Sciences,Inc. (Nasdaq: HGSI ) announced today that ... of its ACHIEVE clinical trials of Albuferon(R) (albinterferon,alfa-2b) for ... who have,been receiving the 1200-mcg dose will now receive ... by the studies, independent Data,Monitoring Committee (DMC). HGS continues ...
Other Medicine Technology:U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims 2Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 2Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 3Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 4Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: